Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Psychoses; Mania; Schizophrenia Age: Adult |
Dose: Intramuscular – 12.5 mg Note: Initially, adjusted according to response; as decanoate |
|
Indication: Psychoses; Mania; Schizophrenia Age: Adult |
Dose: Intramuscular – 12.5-100 mg Frequency: at intervals of 2-6 weeks Note: Maintenance; for doses greater than 50 mg, increments should be made slowly in steps of 12.5 mg; as decanoate |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Child |
Dose: Not applicable – Safety and efficacy not established Note: Safety and efficacy not established |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal impairment |
Dose: Form not specified – Dose not specified Note: Use with caution; monitor |
Administration
- For deep IM injection only
- Give by healthcare professional
Side Effect
- Confusion
- Decreased gag reflex
- Akathisia
- Dystonia
- Dyskinesia
- Muscle stiffness
- Neuroleptic malignant syndrome (NMS
- infrequent but serious)
- Parkinsonism
- Tardive dyskinesia
- Anticholinergic effects
- Sedation
- Weight gain
- Erectile dysfunction
- Oligomenorrhea or amenorrhea
- Orthostatic hypotension (after IM injection)
- tachycardia
- Agitation
- anxiety
- cerebral edema
- depression
- dizziness
- euphoria
- headache
- poikilothermia
- restlessness
- weakness
- Anorexia
- constipation
- dyspepsia
- ileus
- Lens opacities (with prolonged use)
- ECG changes
- Photosensitivity
- Pruritus
- Diarrhea
- Blood dyscrasia
- Galactorrhea
- Ejaculatory disorder
- Seizure
- Priapism
- Cholestatic jaundice
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Guanethidine, methyldopa, clonidine
|
Reduces antihypertensive effects
|
|
Lithium
|
Toxicity
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Comatose states
|
Can worsen condition
|
|
Blood dyscrasias
|
Risk of blood disorders
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store at 15-30°C.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.